Hiroki Inui

1.0k citations
27 papers · 885 · h-index 13

Impact in

    • Carcinogens and Genotoxicity Assessment
  • Oncology top 10%
    • Cancer survivorship and care
    • Cancer-related Molecular Pathways
    • PARP inhibition in cancer therapy

Papers in

    • Breast Cancer Treatment Studies 4
    • Carcinogens and Genotoxicity Assessment 4
    • Cancer-related Molecular Pathways 4
    • Colorectal Cancer Treatments and Studies 3
    • Cancer survivorship and care 3

Hiroki Inui

25 papers receiving 860 citations

Peers

Hiroki Inui
Comparison fields: 5 of 78
  • Cancer Research 201
  • Oncology 247
  • Molecular Biology 526
  • Pathology and Forensic Medicine 62
  • Genetics 79
Replace Maria Bellenghi with:
Maria Bellenghi Italy
Andrea Clocchiatti United States
Dorthe Gylling Crüger Denmark
Moritz Friedo Meyer Germany
Kristin Baker Niendorf United States
CM Steel United Kingdom
Amy N. Allen United States
Kelly T. Huynh United States
Kristin Bosse Germany
Charles Link United States
Hiroki Inui relative to Maria Bellenghi Italy Maria Bellenghi's profile →
Citations per field
00.5×1.5×2.1×
Maria Bellenghi · 1×
Citations per year

Countries citing papers authored by Hiroki Inui

Since Specialization
Citations

This map shows the geographic impact of Hiroki Inui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Inui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Inui more than expected).

Fields of papers citing papers by Hiroki Inui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Inui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Inui. The network helps show where Hiroki Inui may publish in the future.

Co-authors

The 25 scholars most cited alongside Hiroki Inui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroki Inui Line = papers co-authored together Hiroki Inui links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1999113
2 2006111
3 200286
4 200578
5 199972
6 200871
7 201369
8 200653
9 200845
10 200743
11 199843
12 199318
13 199614
14 201813
15 201112
16 200810
17
Relationship between thymidylate synthase (TYMS) gene polymorphism and TYMS protein levels in patients with high-risk breast cancer.
20108
18 20047
19 20007
20 19944

About Hiroki Inui

Hiroki Inui is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Molecular Biology and Surgery, having authored 27 papers that have together received 885 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (8 papers), Breast Cancer Treatment Studies (4 papers), Genetic factors in colorectal cancer (4 papers), Carcinogens and Genotoxicity Assessment (4 papers), Cancer-related Molecular Pathways (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Porphyrin Metabolism and Disorders (3 papers) and Cancer survivorship and care (3 papers). The work is most often cited by research in Cancer Research (201 citations), Oncology (247 citations), Molecular Biology (526 citations), Pathology and Forensic Medicine (62 citations) and Genetics (79 citations). Hiroki Inui has collaborated with scholars based in Japan, United States and Israel. Frequent co-authors include Masahiro Watatani, Atsuko Koyama, Eun-Jung Shim, Masayuki Yasutomi, Anja Mehnert, Nam-Sun Paik, Uwe Koch, Kiyoshi Miyagawa, Nanao Kamada and Kenji Kamiya. Their work appears in journals such as Surgery Today, Journal of Investigative Dermatology, Breast Cancer, Oncogene and Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact